Foreword

Login or register to view PDF.
Received date
15 March 2018
Accepted date
15 March 2018
Citation
US Cardiology Review 2018;12(1):7
DOI
https://doi.org/10.15420/usc.2018.12.1.FO1

The Editorial Board and staff are pleased to present the latest issue of US Cardiology Review. There are 12 very relevant review papers covering four cardiovascular subspecialties.

The issue leads with an update on heart failure with preserved ejection by Drs Birati and Soni, and is followed by a review of fulminant myocarditis by Dr Seif and colleagues. The early recognition and guided therapy in these conditions is critical to improved survival. Next, Dr Lu discusses how the interaction between diabetes and race carries significant implications for the management and prevention of heart failure. In the subsequent section, there are three papers addressing current issues in structural interventional cardiology. The increasing role of interventional echocardiography in guiding transcatheter structural procedures is reviewed by Dr Arjoon and colleagues. Drs Young and Elmariah next provide an interesting historical perspective on the rapid evolution of transcatheter aortic valve replacement, and Dr Younes and colleagues offer a timely, focused update on the issue of leaflet thrombosis following these procedures. This section concludes with an important statement by Dr Dehmer and colleagues on the implications of the appropriate use criteria mandate for ordering certain cardiac imaging procedures that is scheduled for implementation in 2020. Following are two papers in the Risk Prevention section. Dr Alrifai and colleagues provide a thorough discussion of the diagnosis and implications of microvascular dysfunction in adverse cardiovascular outcomes, and Drs Kelly and Cutlip review the recent data for improved cardiovascular outcomes with newer glucose-lowering medications, and discuss the implications of these findings for the treatment of type 2 diabetes. This issue concludes with three papers in the Electrophysiology section. Drs Liang and McBride provide a contemporary review of the role and outcomes of ablation for the treatment of ventricular tachycardia. These procedures are increasing in frequency, and it is helpful to have a current discussion of the evidence. This is followed by two papers on contemporary device therapy alternatives. Drs Yuyun and Chaudhry review His bundle pacing as an alternative to RV or bi-ventricular pacing, and Dr Turnage and colleagues review the role of subcutaneous ICD as an alternative to transvenous lead placement.

We think this compilation of papers is applicable to a number of contemporary practice situations. As usual, we thank the authors and our reviewers for their efforts, and we hope the reviews will be useful in the care of your patients.